P
Peter S. Turk
Researcher at NewYork–Presbyterian Hospital
Publications - 15
Citations - 1830
Peter S. Turk is an academic researcher from NewYork–Presbyterian Hospital. The author has contributed to research in topics: Sentinel lymph node & Breast cancer. The author has an hindex of 13, co-authored 15 publications receiving 1793 citations. Previous affiliations of Peter S. Turk include Roger Williams Medical Center & University of Louisville.
Papers
More filters
Journal ArticleDOI
Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.
Kelly M. McMasters,Todd M. Tuttle,David J. Carlson,C. Matthew Brown,R. Dirk Noyes,Rebecca L. Glaser,Donald J. Vennekotter,Peter S. Turk,Peter S. Tate,Armando Sardi,Patricia B. Cerrito,Michael J. Edwards +11 more
TL;DR: In multi-institutional practice, sentinel lymph node biopsy using dual-agent injection provides optimal sensitivity for detection of nodal metastases and indicates that this procedure is a suitable alternative to routine axillary dissection across a wide spectrum of surgical practice and hospital environments.
Journal ArticleDOI
Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.
Kelly M. McMasters,Sandra L. Wong,Robert C.G. Martin,Celia Chao,Todd M Tuttle,R. Dirk Noyes,David J. Carlson,Alison L. Laidley,Terre Q. McGlothin,Philip B. Ley,C. Matthew Brown,Rebecca L. Glaser,Robert E. Pennington,Peter S. Turk,Diana Simpson,Patricia B. Cerrito,Michael J. Edwards +16 more
TL;DR: Dermal injection of radioactive colloid significantly improves the SLN identification rate compared with peritumoral or subdermal injection, and the false-negative rate is also minimized by the use of dermal injection.
Journal ArticleDOI
Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques
Kelly M. McMasters,Sandra L. Wong,Celia Chao,Claudine Woo,Todd M Tuttle,R. Dirk Noyes,David J. Carlson,Alison L. Laidley,Terre Q. McGlothin,Philip B. Ley,C. Matthew Brown,Rebecca L. Glaser,Robert E. Pennington,Peter S. Turk,Diana Simpson,Michael J. Edwards +15 more
TL;DR: Surgeons should perform at least 20 SLN cases with acceptable results before abandoning routine axillary dissection, and this study provides a model for surgeon training and experience that may be applicable to the implementation of other new surgical technologies.
Journal ArticleDOI
Preoperative Lymphoscintigraphy for Breast Cancer Does Not Improve the Ability to Identify Axillary Sentinel Lymph Nodes
Kelly M. McMasters,Sandra L. Wong,Todd M Tuttle,David J. Carlson,C. Matthew Brown,R. Dirk Noyes,Rebecca L. Glaser,Donald J. Vennekotter,Peter S. Turk,Peter S. Tate,Armando Sardi,Michael J. Edwards +11 more
TL;DR: Routine preoperative lymphoscintigraphy is not necessary for the identification of axillary SLNs in breast cancer, and there was no statistically significant difference in the SLN identification rate, false-negative rate, or number of SLNs removed when a preoperativeymphoscintigram was obtained.
Journal ArticleDOI
Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer : Results of a multi-institutional study
Robert C.G. Martin,Michael J. Edwards,Sandra L. Wong,Todd M Tuttle,David J. Carlson,C. Matthew Brown,R. Dirk Noyes,Rebecca L. Glaser,Donald J. Vennekotter,Peter S. Turk,Peter S. Tate,Armando Sardi,Patricia B. Cerrito,Kelly M. McMasters +13 more
TL;DR: These data support the policy that all blue nodes and all nodes with 10% or more of the ex vivo count of the hottest SLN should be harvested for optimal nodal staging.